Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Uterine
Study Phase
Phase 3
Study Completion Date
June 2018
NCT01533207Uploaded 02-12-2020
Access via NCI by Request
PDS UID - nci-data-405
A Phase III Randomized Trial of Gemcitabine (NSC# 613327) Plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NSC# 123127) Versus Observation for Uterus-Limited, High Grade Uterine Leiomyosarcoma
Files: NCT01533207-D1
Data DictionaryNCT01533207-D1-Data-Dictionary_1.pdf
DATANCT01533207-D1-Dataset_1.csv
OTHERREADME.pdf
Files: NCT01533207-D2
Data DictionaryNCT01533207-D2-Data-Dictionary_2.pdf
DATANCT01533207-D2-Dataset_1.csv
OTHERREADME.pdf